Search

everythinglearnresearchcommunity

for

Search:↓

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

Neurotrophins may contribute to genetic hair thinning by inhibiting hair growth.

PC-associated alopecia has unique microscopic features.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Alopecia areata incognita causes sudden hair thinning, responds well to steroids, and is more common in those with genetic hair loss conditions.

Androgenic alopecia causes hair thinning, and treatments include minoxidil, finasteride, and light therapy.

Trichoscopy can diagnose monilethrix, a genetic hair defect causing hair thinning and loss.

The document concludes that early diagnosis is key for treating common baldness in women, but reassurance is often the best approach as hair thinning can be a normal part of aging.

Skin problems in the elderly are unique and may indicate other diseases, involving changes in skin, hair, nails, and increased cancer risk.

Androgenetic alopecia is a common type of hair loss in men and women, caused by a testosterone byproduct affecting hair follicles, with sensitivity determined by genetics.

New treatments for hair loss are being researched for better effectiveness and safety.

Minoxidil solution can effectively treat hair thinning in women.

Early diagnosis and less aggressive hair care improve outcomes for Black women with frontal fibrosing alopecia.

Male pattern baldness is a genetic condition causing hair loss, with limited but improving treatment options.

Androgenetic alopecia is linked to aging due to inflammation, oxidative stress, and hormonal changes.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Minoxidil and finasteride are effective long-term treatments for male hair loss.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Male pattern baldness is partly caused by specific genes, but most genetic factors are still unknown.

Androgenic Alopecia, a common hair loss condition, can be effectively treated with finasteride and other treatments.

Different hair and scalp disorders cause hair loss or excess hair growth, with various treatments available depending on the specific condition.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

PCOS often causes skin issues like excess hair, acne, hair thinning, and dark patches due to hormone imbalances and insulin resistance.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Early balding, premature graying, and hair thinning can predict heart disease in young Asian males.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.